Debio 9902 - ZT-1 - Debiopharm

Home » Media » Press Releases

Debio 9902 - ZT-1

Date	Article Title
21 Oct 2008	Clinical Update – Debio 9902 SR (ZT-1) for Alzheimer Patients - Debiopharm Starts Tablet Formulation Bridging Study under IND
04 Mar 2008	Clinical Update – Debio 9902 SR in Alzheimer’s disease
10 Jun 2007	Clinical update - Debio 9902 (ZT-1) for Alzheimer´s disease
27 Feb 2007	Clinical update-Debio-9902 SR (ZT-1) implant for Alzheimer´s disease-First patients enroll in Phase II "BRAINz" study
25 Apr 2006	Debiopharm presents phase I monthly implant and phase II daily oral results of ZT-1 for Alzheimer´s disease
13 May 2004	Debiopharm exercises its Option and signs a License Agreement with the Shanghai Institute of Materia Medica for the Development and Commercialisation of ZT-1
06 Nov 2003	Debiopharm presents results of a first monthly injectable sustained-release fomulation of ZT-1 for Alzheimer´s Disease
20 Oct 2003	Debiopharm SA starts a Phase II trial for a once daily oral formulation of ZT-1 to treat Alzheimer´s
21 Jun 2002	H3 Pharma announces promising developments for the treatment of Alzheimer´s disease

Latest News

09 November 2011 Augurix Diagnostics receives the 2011 ‘Debiopharm /Valais Award’ For its point-of-care diagnostic test for the early detection of Celiac disease

05 October 2011 The Japanese Cancer Association and Debiopharm Group™ present Doctors Arakawa and Kurokawa with the 2011 ‘JCA-Mauvernay Award’for their innovative and outstanding research in the field of cancer

08 September 2011 Debiopharm Group™ presents the ‘Debiopharm Group™ Life Sciences Award 2011’ and two ‘Junior Debiopharm Group™ Awards 2011’ at the ISREC 2011 Life Sciences Symposium

Debiopharm on

© 2012 Debiopharm Group